Journal
CELL
Volume 167, Issue 7, Pages 1829-+Publisher
CELL PRESS
DOI: 10.1016/j.cell.2016.11.017
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research Doctoral Award
- NIH [K99 GM117268, R01 GM115911]
- Canadian Institutes of Health Research grants [MOP-130482, MOP-136845]
Ask authors/readers for more resources
CRISPR-Cas9 technology would be enhanced by the ability to inhibit Cas9 function spatially, temporally, or conditionally. Previously, we discovered small proteins encoded by bacteriophages that inhibit the CRISPR-Cas systems of their host bacteria. Theseanti-CRISPRs'' were specific to type I CRISPR-Cas systems that do not employ the Cas9 protein. We posited that nature would also yield Cas9 inhibitors in response to the evolutionary arms race between bacteriophages and their hosts. Here, we report the discovery of three distinct families of anti-CRISPRs that specifically inhibit the CRISPR-Cas9 system of Neisseria meningitidis. We show that these proteins bind directly to N. meningitidis Cas9 (NmeCas9) and can be used as potent inhibitors of genome editing by this system in human cells. These anti-CRISPR proteins now enable off-switches'' for CRISPR-Cas9 activity and provide a genetically encodable means to inhibit CRISPR-Cas9 genome editing in eukaryotes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available